AnaBios Corp:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:AnaBios Corp - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C10643
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:21
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
AnaBios Corp (AnaBios) is a pre-clinical stage contract research organization that offers drug efficacy studies on human samples. The organization’s products portfolio includes human dorsal root ganglia neuron cultures, human cardiac mesenchymal stem cells, human heart tissue samples, human lung samples, human eye samples, human brain tissue samples, human retinal cell cultures, human spinal cord tissue samples, and others. It provides its products in the therapeutic areas of pain, respiratory, cardiac, central nervous system, and ophthalmic. AnaBios offers services such as electrophysiology-based drug profiling, myocardial tissue contractility, imaging-based drug profiling, inhibition of NGF signaling pathway, and drug safety services, among others. The organization employs Phase-X proprietary technology for drug discovery. It serves biotechnology and pharmaceutical industries. AnaBios is headquartered in San Diego, California, the US.

AnaBios Corp – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
AnaBios Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
AnaBios Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
AnaBios Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
AnaBios Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
AnaBios Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
AnaBios Corp, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
AnaBios Raises USD10 Million in Series B Financing 10
AnaBios Raises USD3.6 Million Financing 11
Partnerships 12
AnaBios and Sanofi Enter into Agreement 12
Purdue Pharma to Form Joint Venture with AnaBios 13
Licensing Agreements 14
Purdue Pharma Enters into Licensing agreement with AnaBios 14
Zalicus Enters into Licensing Agreement with AnaBios for Sodium Channel Pain Modulation Program 15
AnaBios Corp – Key Competitors 16
AnaBios Corp – Key Employees 17
AnaBios Corp – Locations And Subsidiaries 18
Head Office 18
Recent Developments 19
Corporate Communications 19
May 22, 2018: AnaBios Announces the Hire of Dr. Chris Mathes as Chief Commercial Officer 19
Product News 20
Jan 23, 2018: Frontiers in Physiology Publishes Research Showing Pro-Arrhythmia Risk Predictivity of Adult Human Primary Ventricular Tissue-Based Model 20
Appendix 21
Methodology 21
About GlobalData 21
Contact Us 21
Disclaimer 21

List of Tables
AnaBios Corp, Pharmaceuticals & Healthcare, Key Facts 2
AnaBios Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
AnaBios Corp, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
AnaBios Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
AnaBios Corp, Deals By Therapy Area, 2012 to YTD 2018 8
AnaBios Corp, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
AnaBios Raises USD10 Million in Series B Financing 10
AnaBios Raises USD3.6 Million Financing 11
AnaBios and Sanofi Enter into Agreement 12
Purdue Pharma to Form Joint Venture with AnaBios 13
Purdue Pharma Enters into Licensing agreement with AnaBios 14
Zalicus Enters into Licensing Agreement with AnaBios for Sodium Channel Pain Modulation Program 15
AnaBios Corp, Key Competitors 16
AnaBios Corp, Key Employees 17

List of Figures
AnaBios Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
AnaBios Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
AnaBios Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
AnaBios Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
AnaBios Corp, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
AnaBios Corp, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
AnaBios Corp, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
AnaBios Corp, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[AnaBios Corp:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • IFA Hotels and Resorts Company KSCC:企業の戦略・SWOT・財務情報
    IFA Hotels and Resorts Company KSCC - Strategy, SWOT and Corporate Finance Report Summary IFA Hotels and Resorts Company KSCC - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • Tanabe Research Laboratories USA Inc-製薬・医療分野:企業M&A・提携分析
    Summary Tanabe Research Laboratories USA Inc (TRL), a subsidiary of Mitsubishi Tanabe Pharma Corp, is a healthcare research center that discovers biological drugs. The center conducts research on metabolics, inflammation and immunology. Its products are used for the therapy of serious diseases with …
  • La Mancha Holding SaRL:企業の戦略・SWOT・財務情報
    La Mancha Holding SaRL - Strategy, SWOT and Corporate Finance Report Summary La Mancha Holding SaRL - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • TenCate Advanced Armour:企業の戦略・SWOT・財務分析
    TenCate Advanced Armour - Strategy, SWOT and Corporate Finance Report Summary TenCate Advanced Armour - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • InMed Pharmaceuticals Inc (IN):企業の財務・戦略的SWOT分析
    Summary InMed Pharmaceuticals Inc (InMed), formerly Cannabis Technologies Inc, is a pre-clinical stage biopharmaceutical company which develops, produces and markets plant cannabinoid based medicines. The company's pipeline products include INM-750, INM-405, and INM-085. Its products finds applicati …
  • S-Oil Corporation Inc (010950):企業の財務・戦略的SWOT分析
    S-Oil Corporation Inc (010950) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • BASF India Ltd (BASF):企業の財務・戦略的SWOT分析
    Summary BASF India Ltd (BASF) a subsidiary of BASF SE is a chemical company that manufactures and distributes specialty chemicals, performance products, plastics and crop protection products. The company offers chemical products such as intermediates, monomers and petrochemicals. Its performance pro …
  • South32 Ltd:企業の戦略・SWOT・財務情報
    South32 Ltd - Strategy, SWOT and Corporate Finance Report Summary South32 Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate act …
  • Spine Injury Solutions Inc (SPIN):企業の財務・戦略的SWOT分析
    Summary Spine Injury Solutions Inc (SPIN), formerly Spine Pain Management Inc is a medical service provider that provides medical technology and healthcare management solutions for liability spine injuries. The company provides services such as clinical management, and billing and collection of medi …
  • Jacobs Engineering Group Inc (JEC):企業の財務・戦略的SWOT分析
    Jacobs Engineering Group Inc (JEC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Air Total International SA:企業の戦略的SWOT分析
    Air Total International SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • PG&E Corp (PCG):企業の財務・戦略的SWOT分析
    PG&E Corp (PCG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • BB Biotech AG (BION):企業の財務・戦略的SWOT分析
    Summary BB Biotech AG (BB Biotech) is a financial service provider that offers biotechnology investments. The company invests in markets that develop new drugs and therapies for use in the treatment of autoimmune and infectious diseases, oncology disorders, cardiovascular diseases, and metabolic dis …
  • Lockton, Inc:企業の戦略・SWOT・財務情報
    Lockton, Inc - Strategy, SWOT and Corporate Finance Report Summary Lockton, Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Ashoka Buildcon Ltd (ASHOKA):企業の財務・戦略的SWOT分析
    Ashoka Buildcon Ltd (ASHOKA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Mangalore Chemicals & Fertilizers Ltd (MANGCHEFER):企業の財務・戦略的SWOT分析
    Summary Mangalore Chemicals & Fertilizers Ltd (MCFL), a subsidiary of Zuari Fertilisers and Chemicals Ltd, is a chemical company that manufactures and markets fertilizers, plant nutrition products, and plant protection chemicals. The company offers urea, di-ammonium phosphate, granulated fertilizers …
  • Gibson Energy Inc (GEI):石油・ガス:M&Aディール及び事業提携情報
    Summary Gibson Energy Inc (Gibson) is an independent midstream energy company. It provides integrated services to the oil and gas industry. The company transport, store, blend, process, market and distribute crude oil, condensate, natural gas liquids, water, oilfield waste, and refined products. Gib …
  • APPH Limited:企業の戦略・SWOT・財務情報
    APPH Limited - Strategy, SWOT and Corporate Finance Report Summary APPH Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Equinor ASA (EQNR):企業の財務・戦略的SWOT分析
    Equinor ASA (EQNR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Erytech Pharma SA (ERYP):企業の財務・戦略的SWOT分析
    Summary Erytech Pharma SA (ERYTECH Pharma) is a clinical-stage biopharmaceutical company developing red blood cell-based therapeutics for cancer and orphan diseases. Its pipeline product candidates include erymethionase (methionine-?-lyase), a novel amino acid agent targeting cancer metabolism in so …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆